✦ LIBER ✦

PHC6 COST-EFFECTIVENESS OF RIVAROXABANVERSUS ENOXAPARIN FORTHROMBOPROPHYLAXIS AFTER TOTAL HIP REPLACEMENT IN SPAIN

✍ Scribed by A Diamantopoulos; F Forster; M Brosa; M Lees; C Piñol; L Febrer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PHC7 COST-EFFECTIVENESS OF RIVAROXABANVE

✍ A Diamantopoulos; F Forster; M Lees; HP McDonald 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PHC9 COST-EFFECTIVENESS OF RIVAROXABANVE

✍ A Diamantopoulos; F Forster; M Lees; L Gilmour; D Ashley 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PHC8 COST-EFFECTIVENESS OF RIVAROXABANVE

✍ A Diamantopoulos; F Forster; M Brosa; M Lees; L Gilmour; D Ashley; C Piñol 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

PCV11 COST-EFFECTIVENESS OF RIVAROXABAN

✍ Pereira, R; Duran, A; Lindner, L; Toro, W; Arango, CH 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PCV38 COST-EFFECTIVENESS OF RIVAROXABAN

✍ J Kim; R Pollock; S Jung; A Diamantopoulos; M Lees 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Cost-effectiveness of prophylaxis in tot

✍ Guy D. Paiement; Sara J. Wessinger; William H. Harris 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 688 KB